Cancer - Testicular
Testicular cancer is a type of cancer that develops in the testicles, a part of the male reproductive system. In the United States, about 8,000 to 9,000 diagnoses of testicular cancer are made each year. Over his lifetime, a man's chance of getting testicular cancer is roughly 1 in 250. It is most common among males aged 15-40 years. Testicular cancer has one of the highest cure rates of all cancers: in excess of 90%; essentially 100% if it has not spread. Even for the relatively few cases in which the cancer has spread widely, chemotherapy offers a cure rate of at least 50%.
Because testicular cancer is curable (stage I can have a success rate of >95%) when detected early, experts recommend regular monthly testicular self-examination after a hot shower or bath, when the scrotum is looser. Men should examine each testicle, feeling for pea-shaped lumps.
A man with one remaining testis can lead a normal life, because the remaining testis takes up the burden of testerone production and will generally have adequate fertility. However, it is worth the expense of measuring hormone levels before removal of a testicle, and sperm banking may be appropriate for younger men who still plan to have children, since fertility may be lessened by removal of one testicle, and can be severely affected if extensive chemotherapy and/or radiotherapy is done.
Less than five percent of those who have testicular cancer will have it again in the remaining testis. A man who loses both testicles will normally have to take hormone supplements, and will be infertile, but can lead an otherwise normal life.
...More at Wikipedia
Related Links:
Cancer - Testicular
Questions recently asked by other users
Latest Cancer / Oncology News From Medical News Today.
- Mitochondria And Tumor Formation In Stem Cells Linked
- Laser Photoablation Of Renal Pelvic Tumours
- Lifestyle And Testicular Dysfunction: A Brief Update
- Transcorporal Artificial Urinary Sphincter Placement For Incontinence In High-risk Patients After Treatment Of Prostate Cancer
- ImmunoCellular Therapeutics Announces Filing Of Patent Application For A Novel Cancer Stem Cell Vaccine Technology
- Cyclacel Announces Completion Of Enrollment In Phase 2 Trial Of Sapacitabine In Elderly AML
- On The Trail Of A Targeted Therapy For Blood Cancers: Exploring Protein Critical To Blood Cell Development
- Small Intestine Can Sense And React To Bitter Toxins In Food
- JCI Online Early Table Of Contents: Oct. 9, 2008
- Australian Launch Of Medical Data 'Internet'
- Deerfield Urethane Joins Forces With Olivia Newton-John To Encourage Early Detection Of Breast Cancer
